Cancer Genetics, Inc.

Cancer Genetics, Inc.

Cancer Genetics, Inc.

Overview
Date Founded

1999

Headquarters

201 Route 17 North, 2nd Floor, Rutherford, NJ, 07070, USA

Type of Company

Public

Employees (Worldwide)

245

Industries

Medical Products & Equipment
Hospitals & Patient Services
Biotechnology

Company Description

Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomaker solutions, biorepository solutions, consulting, cytogenetics testing, nucleic acid extraction and purification, flow cytometry, Focus::NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ.

Contact Data
Trying to get in touch with decision makers at Cancer Genetics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Chief Financial Officer

Chief Commercial Officer

Director, Molecular Diagnostics

Director, Cytogenetics

Executive Vice President, Precision Medicine & BioPharma Services

Vice President, BioPharma Collaborations & Companion Diagnostics

Vice President of Clinical Affairs & Site Operations

Head-Translational Genomics Section

Director, Reimbursement & Clinical Revenue Cycle Management

Board of Directors

Founder at Equity Dynamics, Inc.

Consultant at Mayo Clinic - Arizona

William E. Snee Chair at Memorial Sloan-Kettering Cancer Center

Managing Partner & Portfolio Manager at C7 Advisors LLC

President at Clinical Research Center of Cape Cod, Inc.

Director, Professor of Neurosurgery & Physiology at The University of Iowa

Senior Research Advisor, Precision Medicine at Viviphi Ltd.

Venture Partner at Wellington Partners GmbH

Member, Board of Directors at Cancer Genetics, Inc.

Paths to Cancer Genetics, Inc.
Potential Connections via
Relationship Science
You
Cancer Genetics, Inc.
Owners & Shareholders
Details Hidden

Stonepine Capital Management focuses primarily, but not exclusively, on equity and equity-related securities in US publicly healthcare companies. The firm seeks to invest in companies whose valuations reflect a material discount to their fundamental value in the healthcare space. Stonepine typically prefers to invest in companies at a price reflecting a discount to current commercial and financial assets alone.The Stonepine Funds' investment objective is to achieve superior absolute returns while preserving capital. They have formed Special Purpose Vehicles (SPVs) whose investment objective may differ because these investments tend to be more concentrated than the Stonepine Funds. Stonepine seeks to achieve their investment objective primarily by investing assets in publicly traded healthcare companies. Stonepine's investment focus is companies with commercial stage products generating sustainable revenue and companies with substantial financial assets (such as cash and royalty income streams).

Details Hidden

Perkins Capital Management seeks to generate a positive real rate of return over an extended period of years for their clients. Investment strategies vary based on the type of account and the client's investment objectives, as well as the style of the individual portfolio manager. the firm's two main account types are equity and balanced.Perkins' approach to equity investing can be characterized as a search for opportunity. Their primary focus is on companies which appear to be undergoing positive change that may not be recognized in the market place. Such changes include new products, processes, strategies or management. They also search for companies that are likely candidates for acquisition by another company. Situations like this could provide higher earnings, and when acknowledged by others in the market place, could result in a higher price earnings ratio. Generally, equity investments will be held for a longer period of time in individual (taxable) accounts than they will be held in a pension or IRA (tax deferred) account. This provides the client with potentially lower capital gains on their taxable accounts.Perkins' fixed income investment approach seeks maximum income consistent with high quality investments. In their balanced accounts, the firm analyzes the outlook for both short-term and long-term interest rates. Perkins assesses both the domestic and international economic scene. In their opinion, the most important factors when selecting fixed income securities are the credit rating, yield curve analysis and liquidity. Perkins prefers a minimum credit rating of A by Moody's or Standard & Poor's rating service. They analyze the yield curves of government, corporate, and municipal bonds looking for inequities in yields which may provide an opportunity. Assessing liquidity requires that the security have excellent marketability.

Details Hidden

Stonepine Capital Management focuses primarily, but not exclusively, on equity and equity-related securities in US publicly healthcare companies. The firm seeks to invest in companies whose valuations reflect a material discount to their fundamental value in the healthcare space. Stonepine typically prefers to invest in companies at a price reflecting a discount to current commercial and financial assets alone.The Stonepine Funds' investment objective is to achieve superior absolute returns while preserving capital. They have formed Special Purpose Vehicles (SPVs) whose investment objective may differ because these investments tend to be more concentrated than the Stonepine Funds. Stonepine seeks to achieve their investment objective primarily by investing assets in publicly traded healthcare companies. Stonepine's investment focus is companies with commercial stage products generating sustainable revenue and companies with substantial financial assets (such as cash and royalty income streams).

Recent Transactions
Details Hidden

Cancer Genetics, Inc. issued . USD Common Stock

Details Hidden

Reprocell, Inc. purchases Cancer Genetics (India) Pvt Ltd. from Cancer Genetics, Inc.

Details Hidden

Reprocell, Inc. purchases Bioserve Biotechnologies (India) Pvt Ltd. from Cancer Genetics, Inc.

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Auditor

Advised onCancer Genetics, Inc. issued Common Stock

Underwriter

Advised onCancer Genetics, Inc. issued Common Stock

Underwriter

Advised onCancer Genetics, Inc. issued Common Stock

Legal Advisor

Advised onCancer Genetics, Inc. issued Common Stock

Legal Advisor

Advised onCancer Genetics, Inc. issued Common Stock

Head of Investment Banking

Advised onCancer Genetics, Inc. issued Common Stock

Advisors & Consultants
Advisor

Former Chief Financial Officer, Secretary & Treasurer at Cancer Genetics, Inc.

Consultant

General Manager at Oncospire Genomics LLC

Publicist

Vice President at Russo Partners LLC

Clients

GlaxoSmithKline Plc is a global healthcare company which engages in developing, manufacturing, and marketing of pharmaceutical products including vaccines, over the counter medicines and health-related consumer products. It operates through the following segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need. In 25 years, Gilead has become a leading biopharmaceutical company with a portfolio of 15 marketed products, a growing pipeline of investigational drugs and approximately 5,000 employees in offices across four continents. Gilead's therapeutic areas of focus include HIV/AIDS, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation

eFFECTOR Therapeutics, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA.

Key Stats and Financials As of 2017
Market Capitalization
$10.8M
Total Enterprise Value
$39.7M
Earnings Per Share
$-1.01
Revenue
$29.1M
Net Profit
$-20.9M
EBITDA
$-16.3M
EBITDAMargin
-55.97%
Total Debt
$11M
Total Equity
$26.8M
Enterprise Value Sales
1.36x
TEVNet Income
-1.9x
Debt TEV
0.28x
Three Year Compounded Annual Growth Rate Of Revenue
41.87%
Five Year Compounded Annual Growth Rate Of Revenue
46.59%
Investors
Details Hidden

William E. Snee Chair at Memorial Sloan-Kettering Cancer Center

Details Hidden

Equity Dynamics focuses on early-stage venture capital investments in technology, medical and healthcare companies located in the US. The firm will participate as a lead investor but this is not a requirement. They will also participate in investments with other venture capital firms.

Details Hidden

MediGen Group provides seed and early-stage capital to new life sciences companies. The firm may fund proof-of-concept experiments and deal conceptualization. Companies should have large growing markets and strong intellectual property. They should also have defined regulatory paths to accelerate product development and mitigate FDA approval risk. MediGen seeks investments in companies with a clear path to monetization with substantial short-term value-creating milestones that allow for multiple exit opportunities and hedges against developmental setbacks

Suppliers
Cleveland Clinic Hospitals & Patient Services | CLEVELAND, OH

Cleveland Clinic operates multispecialty academic medical center and hospitals. It offers outpatient care, primary care, numerous subspecialties and numerous locations. The company was founded in 1921 and is headquartered in Cleveland, OH.

Government of the United States of America Government | Washington, DC

The Government of the United States of America is the federal government of the republic of fifty states that constitute the United States, as well as one capital district, and several other territories. The federal government is composed of three distinct branches: legislative, executive and judicial, whose powers are vested by the U.S. Constitution in the Congress, the President, and the federal courts, including the Supreme Court, respectively.

Stanford University Biotechnology | Palo Alto, CA

Stanford University, located between San Francisco and San Jose in the heart of California's Silicon Valley, is one of the world's leading teaching and research universities. Since its opening in 1891, Stanford has been dedicated to finding solutions to big challenges and to preparing students for leadership in a complex world.

Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

OPKO Health, Inc. Pharmaceuticals - MIAMI, FL

OPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations. The Pharmaceuticals segment includes the pharmaceutical operations acquired in Chile, Mexico, Ireland, Israel, and Spain; and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Abbott Laboratories Pharmaceuticals - Highland Park, Illinois

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cancer Genetics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cancer Genetics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Cancer Genetics, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/cancer-genetics-inc-534133
  • https://relationshipscience.com/organization/cancer-genetics-inc-534133